Watchlist Price Alert

Guardant Health Inc. (GH)

NASDAQ: GH · Real-Time Price · USD

49.13

-0.16 (-0.32%)

At close: Jun 16, 2025, 3:59 PM

Dividends

No dividend history available for Guardant Health Inc..

Pro Subscription

Upgrade now for unlimited access to all data, tools and no ads.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Full Definition

Related Stocks

Company	Dividend Yield
Thermo Fisher Scientific	0.41%
Danaher	0.59%
Agilent	0.84%

Dividend Rankings

GH News

1 week ago · Guardant Health Wins Fast Company's 2025 World Changing Ideas Award for Shield Blood Test for Colorectal Cancer Screening - businesswire.com
1 week ago · New Study Published in ESMO Open Highlights Guardant Reveal's Performance in Detecting Minimal Residual Disease in Patients with Early-Stage Breast Cancer - businesswire.com
2 weeks ago · Why Guardant Health Stock Surged Nearly 9% Higher Today - fool.com
2 weeks ago · Why Is Cancer Diagnostic Guardant Health Stock Trading Higher On Tuesday? - benzinga.com
1 week ago · FDA Grants Breakthrough Device Designation to Guardant Health's Shield Multi-Cancer Detection (MCD) Test - businesswire.com
2 weeks ago · National Comprehensive Cancer Network (NCCN) Updates Colorectal Cancer Screening Guidelines to Include Shield Blood-Based Screening - businesswire.com
2 weeks ago · In Largest Molecular Residual Disease (MRD) Study in Colon Cancer, Guardant Reveal Testing Prior to Chemotherapy Provides Robust Stratification for Risk of Disease Recurrence and Survival to Enable Timely Treatment Decisions - businesswire.com
3 weeks ago · Guardant Health Introduces Nearly a Dozen Groundbreaking Smart Liquid Biopsy Applications for Guardant360 Liquid Test - businesswire.com
3 weeks ago · Guardant Health and Collaborators to Present Over 19 Studies Demonstrating Role of Liquid Biopsy in Advancing Precision Oncology at 2025 ASCO Annual Meeting - businesswire.com
3 weeks ago · Guardant Health Introduces Comprehensive Immunohistochemistry Testing for Solid Tumors - businesswire.com